NCT06522542

Gastric Cancer Complicated With Bleeding

Retrospective Study on Anti-cancer Therapy for Gastric Cancer Patients Complicated With Bleeding

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 200 (estimated)
• Sponsor: Peking University Third Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

To investigate the impact of bleeding on the survival and treatment-related adverse events (TRAEs) of gastric cancer patients.

Detailed description

We will retrospectively enroll patients diagnosed with advanced or metastatic gastric cancer at the Department of Medical Oncology and Radiation Sickness of Peking University Third Hospital. The retrospective study aims to investigate the impact of bleeding on treatment-related adverse events (TRAEs) for gastric cancer patients receiving systematic anticancer treatment, assess the influence of bleeding on the survival of patients.

Conditions

• Gastric Cancer

Interventions

Type	Name	Description
DRUG	systematic therapy	All patients received systematic therapy including chemotherapy, targeted therapy or immune checkpoint inhibitor. We aims to investigate the impact of bleeding on the survival and treatment-related adverse events (TRAEs) of gastric cancer patients.

Timeline

• Start date: 2024-08-01
• Primary completion: 2025-07-31
• Completion: 2026-07-31
• First posted: 2024-07-26
• Last updated: 2024-07-26